
About Xellia Pharmaceuticals Private Limited
Data last updated:
Xellia Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Xellia Pharmaceuticals Aps Denmark. It operates in the business support services segment of the business services sector. It was incorporated on 13 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2010PTC055122. Its GSTIN is 29AAACX0896L1ZO (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Soren Hostrup and Eva Blem.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.32 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹2.28 Cr (net margin 8%) and EBITDA of ₹3.71 Cr (EBITDA margin 13.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 12% over five years.
The company has about 93 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Xellia Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xellia.com.
Company details
Contact details
Xellia Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is xellia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit Ps – 9 Tower 2 8th Floor Of M/S. Sumadhura Capitol Towers Pvt Ltd, Sy. No. 14 & 158 Pattandur Agrahara Village K R Puram Hobli Bengaluru East Bengaluru, Bangalore, Karnataka, India – 560066
- IndustryBusiness Services, Business Support Services
To see the full contact details of Xellia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Xellia Pharmaceuticals operates one associated brand: Xellia Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of active pharmaceutical ingredients and finished dosage forms | xellia.com |
Business activity
The main business activity of Xellia Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Xellia Pharmaceuticals Private Limited, buy the company report.
Financials of Xellia Pharmaceuticals Private Limited
FY 2025 filings availableXellia Pharmaceuticals Private Limited reported revenue of ₹28.32 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 16% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.1% | ||||
| Net Profit Margin | 8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xellia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xellia Pharmaceuticals Private Limited
Xellia Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Soren Hostrup | Director | 20 Aug 2024 | 2 Years 2 Months | Current |
| Eva Blem | Additional Director | 12 Jan 2026 | 0 Years 10 Months | Current |
| Per Bork Eppers | Additional Director | 12 Jan 2026 | 0 Years 10 Months | Current |
| Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada | Additional Director | 16 Dec 2025 | 0 Years 11 Months | Current |
Auditor
Xellia Pharmaceuticals Private Limited is audited by Kusumadevi R H for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kusumadevi R H | FY 2023 | 212111 |
Shareholding
The shareholding of Xellia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xellia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xellia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xellia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Xellia Pharmaceuticals Private Limited has a workforce of 93 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 93 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Xellia Pharmaceuticals Private Limited, buy the company report.
GST
Xellia Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACX0896L1ZO | Karnataka | Active | 01 Jul 2017 |
| 36AAACX0896L1ZT | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xellia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xellia Pharmaceuticals Private Limited has 12 board changes on record since 2011: 5 appointments and 7 cessations. The latest: Eva Blem was appointed as Additional Director on 12 Jan 2026.
3 earlier events are in the company report.
Frequently asked questions
Xellia Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in business support services, within the business services industry. It was incorporated on 13 September 2010 (16+ years old) and is registered under CIN U24230KA2010PTC055122.
Xellia Pharmaceuticals has 4 current directors:
- Soren Hostrup - Director
- Eva Blem - Additional Director
- Per Bork Eppers - Additional Director
- Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada - Additional Director
The latest financial statements of Xellia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xellia Pharmaceuticals is 29AAACX0896L1ZO, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAACX0896L1ZT (Telangana).
The CIN (Corporate Identification Number) of Xellia Pharmaceuticals is U24230KA2010PTC055122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xellia Pharmaceuticals was incorporated on 13 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Eva Blem was appointed as Additional Director on 12 Jan 2026. Per Bork Eppers was appointed as Additional Director on 12 Jan 2026. Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada was appointed as Additional Director on 16 Dec 2025. Xellia Pharmaceuticals has 12 board changes on record in total.
Xellia Pharmaceuticals can be reached through the website xellia.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Xellia Pharmaceuticals is at Unit Ps – 9 Tower 2 8th Floor Of MS. Sumadhura Capitol Towers Pvt Ltd, Sy. No. 14 & 158 Pattandur Agrahara Village K R Puram Hobli Bengaluru East Bengaluru, Bangalore, Karnataka, India – 560066.
Xellia Pharmaceuticals operates in the business services industry, in the business support services segment.

